What Does the CA 15.3 Test Measure?
This test measures CA 15-3, a tumour-associated marker in the blood. Serial measurements can help with:
- Cancer Monitoring: Supports assessment of tumour activity during follow-up.
- Recurrence Detection: Rising trends may suggest recurrence before symptoms appear (requires clinical correlation).
- Treatment Response: Decreasing values over time often indicate response to therapy.
- Non-cancer Causes: Mild elevations can occur in benign conditions (e.g., liver disease, endometriosis, autoimmune disorders).
CA 15.3 Test: Who Needs It and Why It’s Done
What Symptoms May Call for a CA 15.3 Test?
Your doctor may recommend this test if you have:
- A known history of breast cancer and require monitoring
- Symptoms that could suggest recurrence (e.g., persistent bone pain, fatigue, unexplained weight loss)
- Symptoms suggestive of metastasis (e.g., new lumps, persistent pain, unexplained swelling)
- Ongoing systemic therapy where marker trends may help assess response
Who Should Get a CA 15.3 Test?
This test is commonly used for:
- Patients already diagnosed with breast cancer
- Individuals being monitored after surgery, chemotherapy, radiation, or targeted therapy
- Patients with suspected metastatic or recurrent disease (as part of a broader evaluation)
Why is a CA 15.3 Test Done?
The test is used to monitor disease course in breast cancer. A rising trend may indicate progression, recurrence, or metastasis, whereas a falling trend can suggest response to treatment. Single values are less informative than trends over time.
Importance of a CA 15.3 Test
CA 15-3 is a useful tool for longitudinal monitoring in breast cancer management. It can support clinical decision-making, particularly when interpreted alongside imaging, clinical examination, and other laboratory findings. It should not be used alone to confirm or exclude cancer.
CA 15.3 Test Booking & Reports – Metropolis Healthcare
How to Book the CA 15.3 Test and Get Your Reports?
- Simple Online Booking
Book via the Metropolis Healthcare website or app, select “CA 15.3 Test,” and choose home collection or a lab visit.
- Safe Sample Collection
A trained technician collects the blood sample using sterile technique.
- Sample Tracking Updates
Track sample progress through the Metropolis portal/app.
- Accurate Laboratory Testing
Testing is typically performed using Electrochemiluminescence Immunoassay (ECLIA) in NABL & CAP accredited laboratories.
- Quick & Easy Reports
Reports are usually available within 8 hours via email/WhatsApp and through the Metropolis app.
Is Home Sample Collection for CA 15.3 Test Available Near You?
Yes. Home blood sample collection is generally available, subject to local service coverage. A 3 ml blood sample is typically collected in a gel vacutainer.
How Long Does It Take to Get a CA 15.3 Test Report?
Reports are generally available within 8 hours once the sample reaches the laboratory.
Note: Reporting time and cost may vary based on your location.
Where Can I See or Get CA 15.3 Test Results?
You can access your reports via the Metropolis Healthcare website/app, or receive them by email or WhatsApp. Printed reports may be collected from the nearest Metropolis lab, if required.
Interpreting CA 15.3 Test Results
|
Parameter
|
Normal Range
|
Unit
|
High Values May Indicate
|
|
CA 15.3
|
< 25.0
|
U/mL
|
Breast cancer recurrence/metastasis; may also be elevated in other malignancies and benign conditions
|
Understanding Abnormal CA 15.3 Test Results
|
Result
|
Interpretation
|
|
Normal (< 25 U/mL)
|
No tumour-marker elevation detected; does not fully exclude disease. Clinical correlation required.
|
|
Mildly Elevated
|
May occur with benign conditions such as hepatitis, cirrhosis, benign breast disease, or autoimmune disorders.
|
|
Significantly Elevated
|
May be suggestive of recurrent or metastatic disease; further evaluation (clinical assessment and imaging) is typically required.
|
Note: Serial measurements (trends over time) are often more clinically informative than a single CA 15-3 value.
How Should You Prepare for a CA 15.3 Test?
- No fasting is required; you can eat and drink normally.
- Inform your doctor about ongoing treatments (chemotherapy, targeted therapy, immunotherapy), as trends should be interpreted in context.
- Stay well hydrated before the blood draw.
- Follow any clinician-specific guidance related to timing of testing during treatment cycles.
How Is a CA 15.3 Test Done? (Step-by-Step Procedure)
- Preparation: A tourniquet is applied to the upper arm.
- Cleaning: The puncture site is disinfected.
- Sample Collection: Approximately 3 ml of blood is drawn into a gel vacutainer.
- Processing: The sample is analysed using ECLIA to quantify CA 15-3.
- Reporting: Results are issued with reference ranges and interpretive guidance as applicable.
Conditions That May Affect CA 15.3 Test Accuracy
Diseases That a CA 15.3 Test Can Help Detect or Monitor
- Breast cancer progression, recurrence, or metastatic disease (monitoring use)
- Response to breast cancer treatment (trend monitoring)
- Other malignancies where CA 15-3 may be elevated (supportive, non-specific): ovarian, colon, lung, pancreatic cancers
- Non-malignant conditions that can elevate tumour markers (supportive context): liver disease, autoimmune disorders